Literature DB >> 19668651

[Not Available].

.   

Abstract

Year:  2005        PMID： 19668651      PMCID： PMC2722565     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  24 in total

Review 1.  Varicella infections and varicella vaccine in the 21st century.

Authors:  Marietta Vázquez
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

2.  Varicella vaccine and infection with varicella-zoster virus.

Authors:  Marietta Vázquez; Eugene D Shapiro
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

3.  Postexposure varicella vaccination in siblings of children with active varicella.

Authors:  M B Salzman; C Garcia
Journal:  Pediatr Infect Dis J       Date:  1998-03       Impact factor: 2.129

4.  Acyclovir prophylaxis of varicella in children with renal disease receiving steroids.

Authors:  S L Goldstein; M J Somers; M B Lande; E D Brewer; K L Jabs
Journal:  Pediatr Nephrol       Date:  2000-04       Impact factor: 3.714

5.  Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.

Authors:  T Kumagai; M Kamada; C Igarashi; K Yuri; H Furukawa; S Chiba; H Kojima; A Saito; T Okui; S Yano
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

6.  Oral acyclovir prophylaxis of varicella after intimate contact.

Authors:  T Y Lin; Y C Huang; H C Ning; C Hsueh
Journal:  Pediatr Infect Dis J       Date:  1997-12       Impact factor: 2.129

7.  Effectiveness over time of varicella vaccine.

Authors:  Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

8.  Varicella exposure in a neonatal medical centre: successful prophylaxis with oral acyclovir.

Authors:  M Hayakawa; H Kimura; M Ohshiro; Y Kato; E Fukami; A Yasuda; A Okumura; T Morishima
Journal:  J Hosp Infect       Date:  2003-07       Impact factor: 3.926

9.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.

Authors:  J A Zaia; M J Levin; S R Preblud; J Leszczynski; G G Wright; R J Ellis; A C Curtis; M A Valerio; J LeGore
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.